Cargando…

Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis

The vaginal ring (VR) is a female-initiated drug-delivery platform used for different indications, including HIV pre-exposure prophylaxis (PrEP). We conducted a systematic review of VR acceptability, values and preferences among women in low- and middle-income countries (LMIC) to inform further inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griffin, Jennifer B., Ridgeway, Kathleen, Montgomery, Elizabeth, Torjesen, Kristine, Clark, Rachel, Peterson, Jill, Baggaley, Rachel, van der Straten, Ariane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839883/ https://www.ncbi.nlm.nih.gov/pubmed/31703094 http://dx.doi.org/10.1371/journal.pone.0224898

Ejemplares similares

Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world
por: Ridgeway, Kathleen, et al.
Publicado: (2022)

Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial
por: Mayo, Ashley J., et al.
Publicado: (2021)

Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring
por: Stoner, Marie C. D., et al.
Publicado: (2022)

Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women
por: Shapley-Quinn, Mary Kate, et al.
Publicado: (2022)

Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial
por: Roberts, Sarah T., et al.
Publicado: (2022)

Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa
por: Nel, Annalene, et al.
Publicado: (2016)

Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention
por: Reidy, Meghan, et al.
Publicado: (2019)

Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?
por: Bhavaraju, Neeraja, et al.
Publicado: (2021)

Efficacy is Not Everything: Eliciting Women’s Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment
por: Browne, Erica N., et al.
Publicado: (2019)

Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability
por: Shapley-Quinn, Mary Kate, et al.
Publicado: (2023)

Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis
por: Delvaux, Thérèse, et al.
Publicado: (2021)

End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study
por: Montgomery, Elizabeth T, et al.
Publicado: (2019)

Adherence Support Approaches in Biomedical HIV Prevention Trials: Experiences, Insights and Future Directions from Four Multisite Prevention Trials
por: Amico, K. Rivet, et al.
Publicado: (2013)

Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing(®))
por: Wieder, Devorah R, et al.
Publicado: (2010)

Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial
por: Palanee-Phillips, Thesla, et al.
Publicado: (2018)

Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition
por: Fonner, Virginia A., et al.
Publicado: (2023)

The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy
por: Schurmans, Céline, et al.
Publicado: (2015)

Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa
por: van der Straten, Ariane, et al.
Publicado: (2014)

High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda
por: Kestelyn, Evelyne, et al.
Publicado: (2018)

The Importance of Male Partner Involvement for Women’s Acceptability and Adherence to Female-Initiated HIV Prevention Methods in Zimbabwe
por: Montgomery, Elizabeth T., et al.
Publicado: (2010)

Pregnant and breastfeeding women’s prospective acceptability of two biomedical HIV prevention approaches in Sub Saharan Africa: A multisite qualitative analysis using the Theoretical Framework of Acceptability
por: Sekhon, Mandeep, et al.
Publicado: (2021)

Firmness Perception Influences Women’s Preferences for Vaginal Suppositories
por: Zaveri, Toral, et al.
Publicado: (2014)

The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention
por: van der Straten, Ariane, et al.
Publicado: (2018)

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women
por: Thurman, Andrea Ries, et al.
Publicado: (2018)

Acceptability of a Long-Acting, Multipurpose Vaginal Ring: Findings from a Phase I Trial in the U.S. and Dominican Republic
por: Tolley, Elizabeth E., et al.
Publicado: (2022)

Attitudes and Acceptability on HIV Self-testing Among Key Populations: A Literature Review
por: Figueroa, Carmen, et al.
Publicado: (2015)

An acceptability and safety study of the Duet(® )cervical barrier and gel delivery system in Zimbabwe
por: Montgomery, Elizabeth T, et al.
Publicado: (2010)

Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States
por: Liu, Albert Y, et al.
Publicado: (2021)

Women’s Experiences with Oral and Vaginal Pre-Exposure Prophylaxis: The VOICE-C Qualitative Study in Johannesburg, South Africa
por: van der Straten, Ariane, et al.
Publicado: (2014)

Acceptability and Use of the Diaphragm and Replens(®) Lubricant Gel for HIV Prevention in Southern Africa
por: Montgomery, Elizabeth T., et al.
Publicado: (2009)

Adolescent Girls and Young Women’s Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis
por: Young, Alinda M., et al.
Publicado: (2023)

Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings
por: Zhao, Xinyu, et al.
Publicado: (2022)

Preferred product attributes of a multipurpose vaginal ring: Findings from a phase 1 trial
por: Tolley, Elizabeth E., et al.
Publicado: (2023)

Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study
por: Garcia, Morgan, et al.
Publicado: (2021)

Review of the combined contraceptive vaginal ring, NuvaRing(®)
por: Roumen, Frans JME
Publicado: (2008)

Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention
por: Palanee-Phillips, Thesla, et al.
Publicado: (2015)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings
por: Thurman, Andrea Ries, et al.
Publicado: (2019)

Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa
por: Minnis, Alexandra M., et al.
Publicado: (2019)

End-Users’ Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa
por: Weinrib, Rachel, et al.
Publicado: (2017)

Vaginal rings for delivery of HIV microbicides
por: Malcolm, R Karl, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_16uhtgdju7ffk2ed38jo9jfnhl